[FG] Leuppi Jörg

Kueng, C. et al. (2024) ‘Pulmonary Embolism Management Audit and Machine Learning Analysis of Delayed Anticoagulation in a Swiss Teaching Hospital’, Journal of Clinical Medicine, 13(20), p. 6103. Available at: https://doi.org/10.3390/jcm13206103.

Suchina, J. et al. (2024) ‘Diagnosis and Treatment of Acute Heart Failure: A Retrospective Observational Study and Medical Audit’, Journal of Clinical Medicine, 13(19), p. 5951. Available at: https://doi.org/10.3390/jcm13195951.

Adelakun, Gabriela et al. (2024) ‘Proteinuria Assessment and Therapeutic Implementation in Chronic Kidney Disease Patients — A Clinical Audit on KDIGO (“Kidney Disease: Improving Global Outcomes”) Guidelines’, Journal of Clinical Medicine, 13(17). Available at: https://doi.org/10.3390/jcm13175335.

Boesing, Maria et al. (2024) ‘Effects of serial NT-proBNP measurements in patients with acute decompensated heart failure’, Global Cardiology Science and Practice, 2024(4). Available at: https://doi.org/10.21542/gcsp.2024.31.

Boesing, Maria et al. (2024) ‘The Predictive Performance of Risk Scores for the Outcome of COVID-19 in a 2-Year Swiss Cohort’, Biomedicines, 12(8), p. 1702. Available at: https://doi.org/10.3390/biomedicines12081702.

Baenziger, J. et al. (2024) ‘Post-traumatic growth in parents of long-term childhood cancer survivors compared to the general population: A report from the Swiss childhood cancer survivor study—Parents’, Psycho-Oncology, 33(1). Available at: https://doi.org/10.1002/pon.6246.

Bessat, Cécile et al. (2024) ‘PLUS-IS-LESS project: Procalcitonin and Lung UltraSonography-based antibiotherapy in patients with Lower rESpiratory tract infection in Swiss Emergency Departments: study protocol for a pragmatic stepped-wedge cluster-randomized trial’, Trials, 25. Available at: https://doi.org/10.1186/s13063-023-07795-y.

Espejo, T. et al. (2024) ‘Diagnostic and prognostic value of cardiac troponins in emergency department patients presenting after a fall: A prospective, multicenter study’, Academic Emergency Medicine [Preprint]. Available at: https://doi.org/10.1111/acem.14897.

Lüthi-Corridori, Giorgia et al. (2024) ‘Diagnosis and Therapy of Community-Acquired Pneumonia in the Emergency Department: A Retrospective Observational Study and Medical Audit’, Journal of Clinical Medicine, 13. Available at: https://doi.org/10.3390/jcm13020574.

Terhalle, L. et al. (2024) ‘Nonspecific stress biomarkers for mortality prediction in older emergency department patients presenting with falls: a prospective multicenter observational study’, Internal and Emergency Medicine [Preprint]. Available at: https://doi.org/10.1007/s11739-024-03693-6.

Tinner, Eva Maria Eugenia et al. (2024) ‘Characteristics and feedback of adult survivors of childhood cancer seen in Swiss comprehensive follow-up clinics led by general internists: a prospective cohort study’, BMJ Open, 14(7), p. e081823. Available at: https://doi.org/10.1136/bmjopen-2023-081823.

Boesing, Maria et al. (2023) ‘The Management of Acute Exacerbations in COPD: A Retrospective Observational Study and Clinical Audit’, Journal of Clinical Medicine, 13(1), p. 19. Available at: https://doi.org/10.3390/jcm13010019.

Mathys, Philippe et al. (2023) ‘The Early HOSPITAL Score to Predict 30-Day Readmission Soon After Hospitalization: a Prospective Multicenter Study’, Journal of General Internal Medicine [Preprint]. Available at: https://doi.org/10.1007/s11606-023-08538-0.

Kleinsorge, Lea et al. (2023) ‘Clinical characteristics governing treatment adjustment in COPD patients: results from the Swiss COPD cohort study’, Swiss Medical Weekly, 153(11), p. 40114. Available at: https://doi.org/10.57187/smw.2023.40114.

Mangold, Veronika et al. (2023) ‘Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort’, Journal of Clinical Medicine, 12(20), p. 6636. Available at: https://doi.org/10.3390/jcm12206636.

Mangold, Veronika et al. (2023) ‘Adherence to the GOLD Guidelines in Primary Care: Data from the Swiss COPD Cohort’, Journal of Clinical Medicine, 12(20), p. 6636. Available at: https://doi.org/10.3390/jcm12206636.

Abu Hussein, N.S. et al. (2023) Risk Factors for Recurrent Exacerbations in the General Practitioners Based Swiss Chronic Obstructive Pulmonary Disease (COPD) Cohort. MDPI AG. Available at: https://doi.org/10.20944/preprints202310.0176.v1.

Liechti, Fabian D. et al. (2023) ‘Factors associated with one-year mortality after hospital discharge: A multicenter prospective cohort study’, PLOS ONE, 18(8), p. e0288842. Available at: https://doi.org/10.1371/journal.pone.0288842.

Leuppi, Jörg D. et al. (2023) ‘COPD – eine unterschätzte Erkrankung COPD – An Underestimated Disease La BPCO - une maladie sous-estimée’, Praxis. Schweizerische Rundschau für Medizin. 07.06.2023, 112(7-8), pp. 403–412. Available at: https://doi.org/10.1024/1661-8157/a004049.

Louis, Renaud et al. (2023) ‘Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy’, The Journal of Allergy and Clinical Immunology: In Practice, 11(6), pp. 1759–1770.e7. Available at: https://doi.org/10.1016/j.jaip.2023.03.009.

Isaak J et al. (2023) ‘Diagnostic Workup and Outcome in Patients with Profound Hyponatremia.’, Journal of clinical medicine, 12(10). Available at: https://doi.org/10.3390/jcm12103567.

Jaun F et al. (2023) ‘Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay.’, Biomedicines, 11(5). Available at: https://doi.org/10.3390/biomedicines11051277.

Boesing M et al. (2023) ‘Predictors for Unplanned Readmissions within 18 Days after Hospital Discharge: a Retrospective Cohort Study.’, Praxis, 112(2), pp. 57–63. Available at: https://doi.org/10.1024/1661-8157/a003985.

Abu Hussein, Nebal S. et al. (2023) ‘Risk Factors for Recurrent Exacerbations in the General-Practitioner-Based Swiss Chronic Obstructive Pulmonary Disease (COPD) Cohort’, Journal of Clinical Medicine, 12(20), p. 6695. Available at: https://doi.org/10.3390/jcm12206695.

Becker C. et al. (2023) ‘Patients’ Preference for Participation in Medical Decision-Making: Secondary Analysis of the BEDSIDE-OUTSIDE Trial’, Journal of General Internal Medicine, 38, pp. 1180–1189. Available at: https://doi.org/10.1007/s11606-022-07775-z.

Fischer, F. B. et al. (2023) ‘Legionnaires” disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO)’, Infection, 51(5), pp. 1467–1479. Available at: https://doi.org/10.1007/s15010-023-02014-x.

Fischer FB et al. (2023) ‘ 4. Legionnaires” disease in Switzerland: rationale and study protocol of a prospective national case-control and molecular source attribution study (SwissLEGIO) ’, Infection [Preprint].

Gross S et al. (2023) ‘Occurrence of sensitive topics during ward round: an ancillary analysis of the BEDSIDE-OUTSIDE trial’, BMJ Open [Preprint].

Jaun, Fabienne et al. (2023) ‘Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry’, Respiration, 102(10), pp. 863–878. Available at: https://doi.org/10.1159/000533474.

Jörg D Leuppi et al. (2023) ‘COPD - An Underestimated Disease’, Praxis Bern [Preprint].

Kleinsorge, Lea et al. (2023) ‘Clinical characteristics governing treatment adjustment in COPD patients: results from the Swiss COPD cohort study’, Swiss Medical Weekly, 153(11), p. 40114. Available at: https://doi.org/10.57187/smw.2023.40114.

Komminoth, Mathis et al. (2023) ‘Glucocorticoid withdrawal and glucocorticoidinduced adrenal insufficiency: Study protocol of the randomized controlled «TOASST’ (Taper Or Abrupt Steroid STop) multicenter trial’, PLoS ONE, 18. Available at: https://doi.org/10.1371/journal.pone.0281585.

Komminoth M et al. (2023) ‘Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST’ (Taper Or Abrupt Steroid STop) multicenter trial’, PLoS One [Preprint].

Leuppi, Jörg D. et al. (2023) ‘BPCO : une maladie encore négligée’, Revue Médicale Suisse, 19(840), pp. 1627–1633. Available at: https://doi.org/10.53738/revmed.2023.19.840.1627.

Lüthi-Corridori G et al. (2023) ‘Risk factors for hospital outcomes in pulmonary embolism: A retrospective cohort study.’, Frontiers in medicine, 10, p. 1120977. Available at: https://doi.org/10.3389/fmed.2023.1120977.

Lüthi-Corridori G et al. (2023) ‘Risk factors for hospital outcomes in pulmonary embolism: A retrospective cohort study’, Front Med (Lausanne) [Preprint].

Lüthi-Corridori, Giorgia et al. (2023) ‘Predictors of Length of Stay, Mortality and Rehospitalization in COPD Patients: A Retrospective Cohort Study’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12165322.

Lüthi-Corridori, Giorgia et al. (2023) ‘Predictors of Length of Stay, Rehospitalization and Mortality in Community-Acquired Pneumonia Patients: A Retrospective Cohort Study’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12175601.

Mandovra, N.P. et al. (2023) ‘Factors Affecting Best-Tolerated Dose of Pirfenidone in Patients with Fibrosing Interstitial Lung Disease’, Journal of Clinical Medicine, 12(20), p. 6513. Available at: https://doi.org/10.3390/jcm12206513.

Mbata, Munachimso Kizito et al. (2023) ‘The Correct Indication to Induce Labour in a Swiss Cantonal Hospital’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12206515.

Mbata, Munachimso Kizito et al. (2023) ‘Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12175520.

Mehra, Tarun et al. (2023) ‘Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities’, Cancer Medicine, 12, pp. 12253–12262. Available at: https://doi.org/10.1002/cam4.5919.

Mehra T et al. (2023) ‘Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities’, Cancer Med. [Preprint].

Rageth, Luana et al. (2023) ‘Predictors for Early Unplanned Readmissions’, Praxis, 112(2), pp. 75–81. Available at: https://doi.org/10.1024/1661-8157/a003992.

Rothe T et al. (2023) ‘The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.’, Respiratory medicine, 206, p. 107067. Available at: https://doi.org/10.1016/j.rmed.2022.107067.

Schnyder D et al. (2023) ‘Audit of Asthma Exacerbation Management in a Swiss General Hospital.’, Respiration; international review of thoracic diseases, 102(1), pp. 12–24. Available at: https://doi.org/10.1159/000527268.

Frix AN et al. (2022) ‘Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study.’, ERJ open research, 8(4). Available at: https://doi.org/10.1183/23120541.00273-2022.

Leuppi JD et al. (2022) ‘Understanding physician’s knowledge and perception of chronic cough in Switzerland.’, Current medical research and opinion, 38(8), pp. 1459–1466. Available at: https://doi.org/10.1080/03007995.2022.2057154.

Stanojevic S et al. (2022) ‘ERS/ATS technical standard on interpretive strategies for routine lung function tests.’, The European respiratory journal, 60(1). Available at: https://doi.org/10.1183/13993003.01499-2021.

LEUPPI, J.D. et al. (2022) ‘Novelties in the Treatment of Asthma Nouveautés dans la prise en charge de l’asthme’, Revue Medicale Suisse, 18(787), pp. 1269–1274. Available at: https://doi.org/10.53738/revmed.2022.18.787.1269.

Mathioudakis AG et al. (2022) ‘ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations.’, The European respiratory journal, 59(5). Available at: https://doi.org/10.1183/13993003.02006-2021.

Leuppi, J.D. (2022) ‘COPD Exacerbation Management: Detect early, treat adequately, prevent exacerbations COPD-Exazerbations-Management: Fruh erkennen, adaquat behandeln, Exazerbationen verhindern’, Revue Medicale Suisse, 18(779), pp. 861–862. Available at: https://doi.org/10.53738/REVMED.2022.18.779.861.

Eger K et al. (2022) ‘The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?’, ERJ open research, 8(2). Available at: https://doi.org/10.1183/23120541.00065-2022.

Jaun F et al. (2022) ‘High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.’, Trials, 23(1), p. 114. Available at: https://doi.org/10.1186/s13063-022-06016-2.

Gross S et al. (2022) ‘Perception of physicians and nursing staff members regarding outside versus bedside ward rounds: Ancillary analysis of the randomised BEDSIDE-OUTSIDE trial’, Swiss Medical Weekly, 152(3-4). Available at: https://doi.org/10.4414/smw.2022.w30112.

Asri A et al. (2022) ‘Which hospital workers do (not) want the jab? Behavioral correlates of COVID-19 vaccine willingness among employees of Swiss hospitals.’, PloS one, 17(5), p. e0268775. Available at: https://doi.org/10.1371/journal.pone.0268775.

Gross S et al. (2022) ‘Perception of physicians and nursing staff members regarding outside versus bedside ward rounds: ancillary analysis of the randomised BEDSIDE-OUTSIDE trial’, Swiss Medical Weekly [Preprint].

Vogt S et al. (2021) ‘Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial’, Respiratory Research, 22(1), p. 227. Available at: https://doi.org/10.1186/s12931-021-01822-9.

Tschacher A et al. (2021) ‘Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland.’, Current medical research and opinion, 37(11), pp. 2019–2033. Available at: https://doi.org/10.1080/03007995.2021.1969354.

Becker C et al. (2021) ‘Effect of bedside compared with outside the room patient case presentation on patients” knowledge about their medical care: A randomized, controlled, multicenter trial’, Annals of Internal Medicine, 174(9), pp. 1282–1292. Available at: https://doi.org/10.7326/m21-0909.

Züsli S et al. (2021) ‘Point of care with serial NT-proBNP measurement in patients with acute decompensated heart failure as a therapy-monitoring during hospitalization (POC-HF): Study protocol of a prospective, unblinded, randomized, controlled pilot trial.’, Contemporary clinical trials communications, 23, p. 100825. Available at: https://doi.org/10.1016/j.conctc.2021.100825.

Sivapalan P. et al. (2021) ‘Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.’, Respiratory research, 22(1), p. 155. Available at: https://doi.org/10.1186/s12931-021-01745-5.

Spina G et al. (2021) ‘Nighttime features derived from topic models for classification of patients with COPD.’, Computers in biology and medicine, 132, p. 104322. Available at: https://doi.org/10.1016/j.compbiomed.2021.104322.

Marmy JL et al. (2021) ‘Adherence to GOLD Recommendations among Swiss Pulmonologists and General Practitioners.’, COPD, 18(1), pp. 9–15. Available at: https://doi.org/10.1080/15412555.2020.1859469.

Asri A et al. (2021) ‘Wearing a mask-For yourself or for others? Behavioral correlates of mask wearing among COVID-19 frontline workers.’, PloS one, 16(7), p. e0253621. Available at: https://doi.org/10.1371/journal.pone.0253621.

Gasser B.A. et al. (2021) ‘High-Intensity Interval Training for Heart Failure Patients With Preserved Ejection Fraction (HIT-HF)-Rational and Design of a Prospective, Randomized, Controlled Trial’, Frontiers in Physiology, 12. Available at: https://doi.org/10.3389/fphys.2021.734111.

Leuppi JD et al. (2021) ‘[Novelties in the Treatment of Asthma].’, Praxis, 110(16), pp. 967–974. Available at: https://doi.org/10.1024/1661-8157/a003760.

Leuppi-Taegtmeyer, Anne B. et al. (2021) ‘Antiseizure drugs and risk of developing smoking-related chronic obstructive pulmonary disease or lung cancer: A population-based case-control study’, British Journal of Clinical Pharmacology, 87(3), pp. 1253–1263. Available at: https://doi.org/10.1111/bcp.14501.

Merlo C et al. (2020) ‘Oral corticosteroids for post-infectious cough in adults: study protocol for a double-blind randomized placebo-controlled trial in Swiss family practices (OSPIC trial).’, Trials, 21(1), p. 949. Available at: https://doi.org/10.1186/s13063-020-04848-4.

Menter T et al. (2020) ‘Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.’, Histopathology, 77(2), pp. 198–209. Available at: https://doi.org/10.1111/his.14134.

Mathioudakis AG et al. (2020) ‘Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: The cosaecopd ers task force study protocol’. European Respiratory Society, 6(3). Available at: https://doi.org/10.1183/23120541.00193-2020.

Giezendanner S et al. (2020) ‘Effect of guideline revisions by the Swiss Society of Hypertension on blood pressure control in hypertensive patients from primary care.’, Swiss medical weekly, 150, p. w20279. Available at: https://doi.org/10.4414/smw.2020.20279.

Kohlbrenner D et al. (2020) ‘Handgrip Strength Seems Not to Be Affected by COPD Disease Progression: A Longitudinal Cohort Study.’, COPD, 17(2), pp. 150–155. Available at: https://doi.org/10.1080/15412555.2020.1727428.

Sievi NA et al. (2020) ‘‘Can do, don’t do’ are not the lazy ones: a longitudinal study on physical functioning in patients with COPD.’, Respiratory research, 21(1), p. 27. Available at: https://doi.org/10.1186/s12931-020-1290-9.

Grewe FA et al. (2020) ‘Compliance of Pharmacotherapy with GOLD Guidelines: A Longitudinal Study in Patients with COPD.’, International journal of chronic obstructive pulmonary disease, 15, pp. 627–635. Available at: https://doi.org/10.2147/copd.s240444.

Mandovra NP et al. (2020) ‘High Incidence of New-Onset Joint Pain in Patients on Fluoroquinolones as Antituberculous Treatment.’, Respiration; international review of thoracic diseases, 99(2), pp. 125–131. Available at: https://doi.org/10.1159/000505102.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O’Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ, GALATHEA Study Investigators and TERRANOVA Study Investigators. (2020) ‘Benralizumab for the Prevention of COPD Exacerbations’, NEJMoa1905248. Epub 2019 May 20. [Preprint].

Mathioudakis AG et al. (2020) ‘The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision.’, Eur Respir J. [Preprint]. Available at: https://doi.org/10.1183/13993003.00627-2020.

van Bragt JJMH et al. (2020) ‘Characteristics and treatment regimens across ERS SHARP severe asthma registries.’, Eur Respir J. [Preprint]. Available at: https://doi.org/10.1183/13993003.01163-2019.

Mandovra NP et al. (2019) ‘[Interventionen beim Asthma COPD].’, Therapeutische Umschau. Revue therapeutique, 76(6), pp. 328–336. Available at: https://doi.org/10.1024/0040-5930/a001097.

Chhajed PN et al. (2019) ‘EBUS-TBNA in the rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathy.’, ERJ open research, 5(4). Available at: https://doi.org/10.1183/23120541.00008-2019.

Kernen P et al. (2019) ‘The sensitivity and specificity of the mannitol bronchial challenge test to identify asthma in different populations: a systematic review.’, Swiss medical weekly, 149, p. w20100. Available at: https://doi.org/10.4414/smw.2019.20100.

Steveling-Klein, E.H. et al. (2019) ‘Chronic Rhinosinusitis is Frequent in Chronic Obstructive Pulmonary Disease: a Case Control Study’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.2.11324/v1.

Saha A et al. (2019) ‘Factors affecting outcomes of individualised treatment for drug resistant tuberculosis in an endemic region.’, The Indian journal of tuberculosis, 66(2), pp. 240–246. Available at: https://doi.org/10.1016/j.ijtb.2017.04.001.

Gregoriano, Claudia et al. (2019) ‘Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial’, Respiratory research, 20(1), p. 273. Available at: https://doi.org/10.1186/s12931-019-1219-3.

Handschin, Anja et al. (2019) ‘Cardiovascular risk stratification in primary care patients with arterial hypertension: Results from the Swiss Hypertension Cohort Study (HccH)’, European Journal of Preventive Cardiology, 26(17), pp. 1843–1851. Available at: https://doi.org/10.1177/2047487319856732.

Kind, Sara et al. (2019) ‘Factors associated with cardiorespiratory fitness in a Swiss working population’, Journal of Sports Medicine, 2019, p. 5317961. Available at: https://doi.org/10.1155/2019/5317961.

Leuppi JD et al. (2019) ‘[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma].’, Praxis, 108(7), pp. 469–476. Available at: https://doi.org/10.1024/1661-8157/a003222.

Leuppi JD et al. (2019) ‘[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma].’, Praxis, 108(7), pp. 1–8. Available at: https://doi.org/10.1024/1661-8157/a003250.

Sievi NA et al. (2019) ‘No impact of exacerbation frequency and severity on the physical activity decline in COPD: a long-term observation.’, International journal of chronic obstructive pulmonary disease, 14, pp. 431–437. Available at: https://doi.org/10.2147/copd.s188710.

Urwyler, Pascal et al. (2019) ‘Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort’, Multidisciplinary respiratory medicine, 14(7), p. 7. Available at: https://doi.org/10.1186/s40248-019-0168-5.

Urwyler, Pascal et al. (2019) ‘Reduction of corticosteroid use in outpatient treatment of exacerbated COPD-Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)’, Trials, 20. Available at: https://doi.org/10.1186/s13063-019-3856-8.

Leuppi J. (2019) ‘Obstruktive Lungenkrankheiten: Asthma und COPD. ’, Therapeutische Umschau [Preprint].

Hallstrand TS et al. (2018) ‘ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing.’, The European respiratory journal. 15.11.2018, 52(5). Available at: https://doi.org/10.1183/13993003.01033-2018.

Sievi NA et al. (2018) ‘Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years.’, Respiratory medicine. 18.06.2018, 141, pp. 1–6. Available at: https://doi.org/10.1016/j.rmed.2018.06.013.

Gregoriano, Claudia et al. (2018) ‘Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial’, Respiratory research, 19(1), p. 237. Available at: https://doi.org/10.1186/s12931-018-0936-3.

Hug M et al. (2018) ‘Screening for obstructive sleep apnea among hospital outpatients.’, PloS one. 30.05.2018, 13(5), p. e0198315. Available at: https://doi.org/10.1371/journal.pone.0198315.

Rothe T et al. (2018) ‘Diagnosis and Management of Asthma - The Swiss Guidelines.’, 95(5). Available at: https://doi.org/10.1159/000486797.

Saha A et al. (2018) ‘Combined pirfenidone, azithromycin and prednisolone in post-H1N1 ARDS pulmonary fibrosis.’, 35(1). Available at: https://doi.org/10.36141/svdld.v35i1.6393.

Faller N et al. (2017) ‘Frequency of use and acceptability of clinical prediction rules for pulmonary embolism among Swiss general internal medicine residents.’, Thrombosis research, 160, pp. 9–13. Available at: https://doi.org/10.1016/j.thromres.2017.09.028.